Skip to main content
    M

    MacroGenics Inc (MGNX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.05
    -0.12 (-5.53%)

    Market Cap: $138.68M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    MacroGenics Inc (MGNX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    MacroGenics (MGNX) has a latest price of $2.05 on Nov 17, 2026, 59.6% below its 52-week high of $5.08. Its price rose 36.7% over the past 12 months. The month-end price fell 89.9% over the 10 years through Oct 2026, a compound annual decline of 20.5%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $32.36 in Apr 2021 and its lowest $1.21 in Jun 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MGNX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MGNX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 50.8%, and over 6 months it fell 54.6%. The month-end price fell 54.0% over the 3 years through Oct 2026, a compound annual decline of 22.8%.

    PeriodChange
    1 month-38.4%
    3 months-50.8%
    6 months-54.6%
    12 months+36.7%
    12 months, with dividends+36.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-54.0%-22.8%
    5 years-87.7%-34.2%
    10 years-89.9%-20.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 110.1%, and its weakest was 2024, when it fell 66.2%.

    YearCloseChange
    2026 through Oct 2026$2.40+49.1%
    2025$1.61-50.5%
    2024$3.25-66.2%
    2023$9.62+43.4%
    2022$6.71-58.2%
    2021$16.05-29.8%
    2020$22.86+110.1%
    2019$10.88-14.3%
    2018$12.70-33.2%
    2017$19.00-7.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 36.7% below its 50-day average of $3.24 and 40.5% below its 200-day average of $3.45.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.05
    52-week high$5.08-59.6%
    52-week low$1.32+55.3%
    50-day average$3.24-36.7%
    200-day average$3.45-40.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 95.1%.

    MeasureValue
    1-year beta1.08
    Largest fall, 1 year-57.8%
    Largest fall, 3 years-95.1%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MGNX

    What is MGNX's 1-year price change?

    MacroGenics's price rose 36.7% over the past 12 months. With dividends included, the 12-month total return was 36.7%.

    What is MGNX's 5-year price change?

    MacroGenics's month-end price fell 87.7% over the 5 years through Oct 2026, a compound annual decline of 34.2%. These figures leave out dividends.

    What is MGNX's 52-week high and low?

    MacroGenics's 52-week high is $5.08 and its 52-week low is $1.32. Its latest price of $2.05 on Nov 17, 2026 is 59.6% below the high.

    What is MGNX's beta?

    MacroGenics's 1-year beta against the S&P 500 is 1.08, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 57.8%.

    Is the MGNX chart free?

    Yes. Advanced Charting for MGNX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.